(ALGM) Allegro Microsystems - Overview
Stock: Sensor, Driver, Regulator, Isolator
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 44.1% |
| Relative Tail Risk | -6.30% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.13 |
| Alpha | 41.41 |
| Character TTM | |
|---|---|
| Beta | 1.914 |
| Beta Downside | 1.717 |
| Drawdowns 3y | |
|---|---|
| Max DD | 68.65% |
| CAGR/Max DD | -0.02 |
Description: ALGM Allegro Microsystems January 08, 2026
Allegro Microsystems (NASDAQ: ALGM) designs, develops, manufactures, and markets sensor and power integrated circuits (ICs) for motion-control and energy-efficient applications. Its product portfolio includes magnetic position, speed and current sensors, motor-driver ICs, power-management and LED drivers, as well as isolated gate drivers. The firm sells primarily to original equipment manufacturers (OEMs) and distributors in the automotive and industrial sectors, using a mix of direct sales, third-party distributors, independent reps, and consignment arrangements. Allegro operates globally across the United States, the rest of the Americas, Europe, Japan, Greater China, South Korea, and other Asian markets, and has been headquartered in Manchester, New Hampshire since its 1990 founding.
Key recent metrics (FY 2023): revenue of roughly $210 million, up ~12 % year-over-year, with a gross margin of ~55 % and R&D spending near 15 % of revenue-indicative of a strong reinvestment rate in new sensor technologies. The automotive sensor market, a core driver for Allegro, is projected to grow at a CAGR of ~8 % through 2028, buoyed by electric-vehicle (EV) adoption and advanced driver-assistance systems (ADAS). A material risk is the ongoing semiconductor supply-chain volatility, which could constrain component lead times and pressure pricing in the industrial segment.
For a deeper quantitative analysis, you may find ValueRay’s data platform helpful for tracking Allegro’s valuation trends and peer comparisons.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: -13.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 8.14 > 1.0 |
| NWC/Revenue: 44.57% < 20% (prev 51.08%; Δ -6.51% < -1%) |
| CFO/TA 0.10 > 3% & CFO 147.7m > Net Income -13.2m |
| Net Debt (159.4m) to EBITDA (59.0m): 2.70 < 3 |
| Current Ratio: 3.65 > 1.5 & < 3 |
| Outstanding Shares: last quarter (186.2m) vs 12m ago 1.19% < -2% |
| Gross Margin: 44.96% > 18% (prev 0.47%; Δ 4449 % > 0.5%) |
| Asset Turnover: 58.63% > 50% (prev 53.60%; Δ 5.03% > 0%) |
| Interest Coverage Ratio: -0.24 > 6 (EBITDA TTM 59.0m / Interest Expense TTM 28.0m) |
Altman Z'' 1.40
| A: 0.26 (Total Current Assets 515.4m - Total Current Liabilities 141.1m) / Total Assets 1.42b |
| B: -0.04 (Retained Earnings -52.0m / Total Assets 1.42b) |
| C: -0.00 (EBIT TTM -6.78m / Avg Total Assets 1.43b) |
| D: -0.17 (Book Value of Equity -78.1m / Total Liabilities 458.3m) |
| Altman-Z'' Score: 1.40 = BB |
Beneish M -2.96
| DSRI: 1.09 (Receivables 99.7m/83.8m, Revenue 839.7m/772.8m) |
| GMI: 1.05 (GM 44.96% / 47.22%) |
| AQI: 0.99 (AQ_t 0.41 / AQ_t-1 0.42) |
| SGI: 1.09 (Revenue 839.7m / 772.8m) |
| TATA: -0.11 (NI -13.2m - CFO 147.7m) / TA 1.42b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of ALGM shares?
Over the past week, the price has changed by +12.18%, over one month by +34.20%, over three months by +52.14% and over the past year by +79.67%.
Is ALGM a buy, sell or hold?
- StrongBuy: 8
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ALGM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 44.3 | 5.6% |
| Analysts Target Price | 44.3 | 5.6% |
| ValueRay Target Price | 45 | 7.1% |
ALGM Fundamental Data Overview February 09, 2026
P/S = 9.1726
P/B = 8.0007
Revenue TTM = 839.7m USD
EBIT TTM = -6.78m USD
EBITDA TTM = 59.0m USD
Long Term Debt = 286.2m USD (from longTermDebt, last quarter)
Short Term Debt = 7.43m USD (from shortTermDebt, last quarter)
Debt = 322.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 159.4m USD (from netDebt column, last quarter)
Enterprise Value = 7.86b USD (7.70b + Debt 322.8m - CCE 163.4m)
Interest Coverage Ratio = -0.24 (Ebit TTM -6.78m / Interest Expense TTM 28.0m)
EV/FCF = 64.89x (Enterprise Value 7.86b / FCF TTM 121.2m)
FCF Yield = 1.54% (FCF TTM 121.2m / Enterprise Value 7.86b)
FCF Margin = 14.43% (FCF TTM 121.2m / Revenue TTM 839.7m)
Net Margin = -1.57% (Net Income TTM -13.2m / Revenue TTM 839.7m)
Gross Margin = 44.96% ((Revenue TTM 839.7m - Cost of Revenue TTM 462.2m) / Revenue TTM)
Gross Margin QoQ = 46.73% (prev 46.33%)
Tobins Q-Ratio = 5.53 (Enterprise Value 7.86b / Total Assets 1.42b)
Interest Expense / Debt = 2.81% (Interest Expense 9.08m / Debt 322.8m)
Taxrate = 21.0% (US default 21%)
NOPAT = -5.36m (EBIT -6.78m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 3.65 (Total Current Assets 515.4m / Total Current Liabilities 141.1m)
Debt / Equity = 0.33 (Debt 322.8m / totalStockholderEquity, last quarter 964.4m)
Debt / EBITDA = 2.70 (Net Debt 159.4m / EBITDA 59.0m)
Debt / FCF = 1.32 (Net Debt 159.4m / FCF TTM 121.2m)
Total Stockholder Equity = 940.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.92% (Net Income -13.2m / Total Assets 1.42b)
RoE = -1.40% (Net Income TTM -13.2m / Total Stockholder Equity 940.6m)
RoCE = -0.55% (EBIT -6.78m / Capital Employed (Equity 940.6m + L.T.Debt 286.2m))
RoIC = -0.43% (negative operating profit) (NOPAT -5.36m / Invested Capital 1.25b)
WACC = 12.54% (E(7.70b)/V(8.03b) * Re(12.97%) + D(322.8m)/V(8.03b) * Rd(2.81%) * (1-Tc(0.21)))
Discount Rate = 12.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -2.17%
[DCF Debug] Terminal Value 57.98% ; FCFF base≈74.9m ; Y1≈59.5m ; Y5≈39.7m
Fair Price DCF = 1.32 (EV 404.8m - Net Debt 159.4m = Equity 245.4m / Shares 185.3m; r=12.54% [WACC]; 5y FCF grow -24.63% → 2.90% )
EPS Correlation: -67.23 | EPS CAGR: -8.58% | SUE: 0.16 | # QB: 0
Revenue Correlation: -37.99 | Revenue CAGR: 3.66% | SUE: 2.97 | # QB: 4
EPS next Quarter (2026-06-30): EPS=0.20 | Chg30d=+0.003 | Revisions Net=+2 | Analysts=12
EPS next Year (2027-03-31): EPS=0.94 | Chg30d=-0.030 | Revisions Net=+0 | Growth EPS=+78.2% | Growth Revenue=+17.4%